Skip to main content

Day: August 15, 2023

How Will the Dental Biomaterials Market Transform Itself into a USD 18.46 Billion Powerhouse by 2032?

Increasing prevalence of dental disorders is one of the major factors driving Dental Biomaterials market revenue growth. Vancouver, Aug. 15, 2023 (GLOBE NEWSWIRE) — Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential growth in the near future., has released a report that delves deep into the dynamic landscape of the Dental Biomaterials Market. Dental biomaterials refer to a class of materials specifically designed and used in dentistry to restore, repair, or replace various dental structures, such as teeth, gums, and bones. These materials play a crucial role in ensuring the functionality, aesthetics, and longevity of dental restorations and treatments. Dental biomaterials are subject to rigorous testing, research, and development...

Continue reading

Sodium-ion Battery Market to Surpass 2899 Million by 2030 Drives Due to Rising Industrial Use

SkyQuest projects that the sodium-ion battery market will attain a USD 2899 million value by 2030, with a CAGR of 11.8% over the forecast period (2023-2030). The surging demand for electric vehicles (EVs) acts as a catalyst for the sodium-ion battery market. Anticipated EV sales of 15 million in 2025 and 25 million in 2030 drive sodium-ion battery adoption. Compared to lithium-ion batteries, sodium-ion alternatives are gaining traction due to their sustainability benefits. Westford USA, Aug. 15, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, rising demand for cost-efficient energy storage options drives the sodium-ion battery market. Sodium-ion batteries utilize abundant sodium resources, lowering production costs. This affordability appeals to industries and regions seeking affordable yet efficient energy storage solutions. Browse...

Continue reading

Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results

RICHARDSON, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) — On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, filed its quarterly report on Form 10-Q for the quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”). Second Quarter 2023 Financial HighlightsNet revenues for the quarter ended June 30, 2023 were $5.0 million, compared to $4.7 million for the quarter ended June 30, 2022, which was an increase of approximately 7%.For the quarter ended June 30, 2023, gross profit was $3.5 million, or 69% of revenues, compared to $2.6 million, or 57% of revenues, for the quarter ended June 30, 2022, which was an increase of 31%.Selling, general, administrative, and other expenses...

Continue reading

OKYO Pharma Limited Reports Annual Results for the Twelve Months Ended March 31, 2023

LONDON and NEW YORK, Aug. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED”) to address the significant unmet need in this multi-billion-dollar market, today announced financial results for the twelve months ended March 31, 2023 and provided a corporate update on its lead program in development. Gary Jacob, Chief Executive Officer of OKYO, commented, “We are very pleased at the advancements we have made with our flagship drug OK-101 to treat DED this year. On May 2, 2023, we announced the initiation of our first clinical trial of OK-101 to treat DED. This trial is a 240 patient, phase 2, multi-center, randomized, double-masked, placebo-controlled trial in patients with DED. This summer we are expecting to...

Continue reading

MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION

New York, NY, Aug. 15, 2023 (GLOBE NEWSWIRE) — Moringa Acquisition Corp (Nasdaq: MACA) (“Moringa” or the “Company”) announced today that, in connection with its previously announced extraordinary general meeting in lieu of the 2023 annual general meeting of shareholders of the Company to be held at 9:00 a.m. Eastern Time/4:00 p.m. local (Israel) time on August 16, 2023 (the “Extraordinary Meeting”) for the purpose of considering and voting on, among other proposals, a proposal to extend the date by which the Company must consummate an initial business combination (the “Extension”) from August 19, 2023 (the “Current Termination Date”) to August 19, 2024 or such earlier date as may be determined by the Company’s board of directors, in its sole discretion (such new termination date, the “Extension Date”), the Company’s sponsor, Moringa...

Continue reading

Tandy Leather Factory Reports Second Quarter 2023 Results

FORT WORTH, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the second fiscal quarter 2023, ended June 30, 2023. Second Quarter Highlights:Revenues were $17.5 million, down 5% from 2022 Generated operating income of $0.8 million Net income of $0.5 million Gross margins of 62.5% Adjusted EBITDA* of $1.3 million Ended quarter with $10.0 million of cash and cash equivalentsTandy Leather Factory’s second quarter sales were $17.5 million in 2023, down from $18.4 million in 2022. First quarter 2023 gross profit was $10.9 million, up from $10.5 million in 2022. As of March 31, 2023, the Company held $10.0 million of cash and cash equivalents, up from $8.0 million at year end. The Company held inventory of $37.5 million, down from $38.2 million as...

Continue reading

Wax Market to Surpass 14.16 Billion by 2030 Drives Due to Strong Presence of Local and Multinational Players

SkyQuest projects that the wax market will attain a value of USD 14.16 billion by 2030, with a CAGR of 4.3% over the forecast period (2023-2030). Wax has been witnessing tremendous demand from various industries due to its outstanding characteristics, such as high gloss, good water repellence, and superior chemical resistance. However, the global wax market needs to be more cohesive owing to the strong presence of local and multinational players that aggressively focus on rapid expansion, product innovation, and diversification through R&D activities, mergers and acquisitions, and joint ventures. Westford USA, Aug. 15, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the global wax market is expected to experience significant growth owing to various factors. The rise in the usage of waxes in the packaging industry, driven by...

Continue reading

Amethyst Announces 4 New CBD Wellness Products and EDI Compliancy

RANCHO CORDOVA, CA, Aug. 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Alternative Wellness Health, Inc. (EXMT), is proud to announce our new website that includes 4 additional Amethyst products with EDI compliant capabilities too. Amethyst is proud to announce the launch of 4 new products to our line. Amethyst CBD Freeze, Amethyst Massage Oil, Amethyst Gummies, Amethyst Drink Enhancer. The NEW Amethyst website is live at http://LiveAmethystCBD.com Being EDI compliant for retailers allows smoother ordering and shipping of our products and integration into their processes. An EDI system enables us to transmit large amounts of data to our trading partners without the difficulties of manual communication processes. Amethyst is on track to growing our supply chain partners and streamline communication processes accordingly....

Continue reading

GEMXX Announces First Gold Production from Snow Creek Mine Site

Gold exploration assets include the Snow Creek and Rosella Creek projects, as well as additional options on mining claims located in British Columbia LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) — via IBN – GEMXX Corporation (OTC: GEMZ) (“GEMXX” or the “Company”) announces today the successful completion of its first clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining season, in collaboration with Crazy Horse Mining Inc. (“CHMI”). CHMI, in partnership with GEMXX, has processed a 4,500 cubic yard sample of gold-bearing surface ore stockpiled while building the processing site, providing a positive indication of the resource potential on the property. The initial production results have exceeded expectations, yielding 38.73 ounces of gold from 4,500 cubic yards of surface...

Continue reading

Diabetes Care Devices Market Set to Soar Past USD 57.67 Billion by 2030

The global Diabetes Care Devices market size is expected to reach USD 57.67 billion by 2030 and exhibit a CAGR of 8.7% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of diabetes worldwide, growing awareness about diabetes management and the importance of regular monitoring, technological advancements in diabetes care devices, rising healthcare expenditure and favourable reimbursement policies fuel the market’s growth. Westford, USA, Aug. 15, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Diabetes Care Devices market, increasing adoption of continuous glucose monitoring (CGM) systems, growing demand for insulin delivery devices, integration of advanced technologies such as artificial intelligence (AI) and Internet of Things...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.